4.6 Article

MicroRNA-22: a Novel and Potent Biological Therapeutics in Neurological Disorders

Journal

MOLECULAR NEUROBIOLOGY
Volume 59, Issue 5, Pages 2694-2701

Publisher

SPRINGER
DOI: 10.1007/s12035-022-02769-8

Keywords

MicroRNA-22; Neuroprotective; Neurodegenerative diseases; Brain malignancies; Stroke; RNA therapeutics

Categories

Funding

  1. Mashhad University of medical sciences
  2. ricerca corrente

Ask authors/readers for more resources

This article discusses the protective and therapeutic effects of miR-22 on neurological diseases and injuries, as well as its correlation with other diseases. The research provides a new therapeutic perspective for the application of miR-22 in treating neurological disorders.
MicroRNAs (miRs) are regulatory RNAs with 18-25 nucleotides lengths involved in various biological processes. Some miRs, including miR-22, play an essential role in regulating neurological disorders. MiR-22 is a brain-enriched regulatory element involved in angiogenesis, energy supply, adjustment of ionic channels, and suppression of malignant cell proliferation, migration, and invasion. This article discusses the protective and therapeutic effects of miR-22 on neurological diseases and injuries, including cerebral ischemia, neurodegenerative diseases, epilepsy, and brain malignancies. We also correlated miR-22 with amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), panic disorders, schizophrenia, neural tube defect (anencephaly), and traumatic brain injury. This work provides a therapeutic perspective for miR-22 as a new approach in treating neurological disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available